PFD report

Master Ruben Bousquet · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 18 Dec 2020•Inner South London

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
3

Raised in this report

Recipients
3

Named on the report

Responses found
3

Of 3 recipients

Stated actions
18

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised3

  1. Failure to update the WDRP practical guide to address food allergy deaths
    Part of recurring concern: Unreliable capture and reporting of anaphylaxis incidents
  2. Delays in notifying food allergy fatalities to relevant food-safety oversight functions
    Part of recurring concern: Unreliable capture and reporting of anaphylaxis incidents
  3. Absence of a national process and register for food allergy deaths
    Part of recurring concern: Unreliable national sharing of safety-critical incident information
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.2

  1. Action

    Support the Food Standards Agency’s work to increase information on food-related fatalities.

    Stated by Department of Health and Social CareStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  2. Action

    Develop work to strengthen guidance and support for food businesses.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.2

  1. Position

    Establishing a national register of food-allergy fatalities is outside the respondent’s remit because of other bodies’ medical and clinical responsibilities.

    Stated by Food Standards AgencyOutside remitThe respondent said that this matter was outside its role or authority.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to update the WDRP practical guide to address food allergy deaths

Wider context from the report

“1. Reporting and Registering The Head of Incidents at the FSA informed the court that the FSA has started work on a reporting platform for allergic reactions, but needs access to information on all fatalities if it is to have effective oversight of food safety. It would welcome improved appropriate sharing of information on fatalities as they are not routinely notified in a timely manner when there is a report of a fatality by the local authority or coroner. The Team Leader of Environmental Health in Royal Borough of Greenwich gave evidence that in 2019 the national Work Related Deaths Committee accepted a recommendation that the practical guide of the WDRP should be updated to address concerns surrounding food allergy deaths and the HSE is considering an amendment, but it has not yet been possible to take this forward. The Head of Trading Standards at the Royal London Borough of Greenwich confirmed that there was no national register (the subject of a PFD report from this jurisdiction in November 2019), but stressed that it is not the HSE who investigates these deaths and that a national process was needed that involved the local authorities coroners and FSA. ”

Is this part of a recurring concern?

Yes — Unreliable capture and reporting of anaphylaxis incidents.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Delays in notifying food allergy fatalities to relevant food-safety oversight functions

Wider context from the report

“1. Reporting and Registering The Head of Incidents at the FSA informed the court that the FSA has started work on a reporting platform for allergic reactions, but needs access to information on all fatalities if it is to have effective oversight of food safety. It would welcome improved appropriate sharing of information on fatalities as they are not routinely notified in a timely manner when there is a report of a fatality by the local authority or coroner. The Team Leader of Environmental Health in Royal Borough of Greenwich gave evidence that in 2019 the national Work Related Deaths Committee accepted a recommendation that the practical guide of the WDRP should be updated to address concerns surrounding food allergy deaths and the HSE is considering an amendment, but it has not yet been possible to take this forward. The Head of Trading Standards at the Royal London Borough of Greenwich confirmed that there was no national register (the subject of a PFD report from this jurisdiction in November 2019), but stressed that it is not the HSE who investigates these deaths and that a national process was needed that involved the local authorities coroners and FSA. ”

Is this part of a recurring concern?

Yes — Unreliable capture and reporting of anaphylaxis incidents.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Absence of a national process and register for food allergy deaths

Wider context from the report

“1. Reporting and Registering The Head of Incidents at the FSA informed the court that the FSA has started work on a reporting platform for allergic reactions, but needs access to information on all fatalities if it is to have effective oversight of food safety. It would welcome improved appropriate sharing of information on fatalities as they are not routinely notified in a timely manner when there is a report of a fatality by the local authority or coroner. The Team Leader of Environmental Health in Royal Borough of Greenwich gave evidence that in 2019 the national Work Related Deaths Committee accepted a recommendation that the practical guide of the WDRP should be updated to address concerns surrounding food allergy deaths and the HSE is considering an amendment, but it has not yet been possible to take this forward. The Head of Trading Standards at the Royal London Borough of Greenwich confirmed that there was no national register (the subject of a PFD report from this jurisdiction in November 2019), but stressed that it is not the HSE who investigates these deaths and that a national process was needed that involved the local authorities coroners and FSA. ”

Is this part of a recurring concern?

Yes — Unreliable national sharing of safety-critical incident information.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Support the Food Standards Agency’s work to increase information on food-related fatalities.

Verbatim wording from the response

“We agree that it is essential that we learn from these tragedies. In conjunction with the FSA’s ongoing programme to collect more information on allergic reactions, the Department of Health and Social Care is working to support the FSA to increase information prevalence regarding such fatalities.”

Source location

2020-0298-Response-from-Dept-for-Health-and-Social-Care-Redacted
Page 1 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Develop work to strengthen guidance and support for food businesses.

Verbatim wording from the response

“The above comments address the action suggested in your report, but you may wish to know more about the work the FSA undertakes in this area. Food hypersensitivity is a priority for the FSA. We want to improve the quality of life for people living with food hypersensitivity and support them to make safe, informed food choices to effectively manage risk. Our Food Hypersensitivity Programme builds on the FSA’s extensive work over many years on research, recommending legislation to improving labelling, and the provision of information to customers. To date more than 60 projects have been initiated with an investment of £20 million. The FSA also regularly reviews its guidance and support to food businesses and we are developing several pieces of work to strengthen that support.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 3 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Establishing a national register of food-allergy fatalities is outside the respondent’s remit because of other bodies’ medical and clinical responsibilities.

Verbatim wording from the response

“• Separately, whilst it is not within FSA’s remit to establish a national register of fatalities, given their medical and clinical responsibilities in this area, we are discussing with the Department for Health and Social Care (DHSC) how we could analyse and evaluate different data sources to give us a clearer picture of allergic reactions that result in fatality.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The mechanism for medical authorities to share suspected food-allergy fatality information is outside the respondent’s policy function.

Verbatim wording from the response

“notification is provided. In these cases, a mechanism by which the FSA is made aware of the fatality would be very helpful. Most obviously, this might involve the sharing of information with the FSA by medical authorities, but this is not a matter in respect of which the FSA has a policy function.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.16

  1. 1

    Advance progress towards an effective, safe and legally implemented mechanism for widening access to adrenaline auto-injectors.

    Stated by Medicines and Healthcare products Regulatory AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  2. 2

    Seek expert advice on areas supporting the effective and safe use of adrenaline auto-injectors, including wider availability.

    Stated by Medicines and Healthcare products Regulatory AgencyStated completedThe respondent said that this action was complete when they made their response on 8 January 2021.
  3. 3

    Endorse the Expert Working Group’s conclusions and recommendations on adrenaline auto-injector safety and wider availability.

    Stated by Medicines and Healthcare products Regulatory AgencyStated completedThe respondent said that this action was complete when they made their response on 8 January 2021.
  4. 4

    Establish and convene an Adrenaline Auto-injector Expert Working Group to examine safe use, wider availability and related safeguards.

    Stated by Medicines and Healthcare products Regulatory AgencyStated completedThe respondent said that this action was complete when they made their response on 8 January 2021.
  5. 5

    Publish a report summarising the Expert Working Group’s conclusions and recommendations by the end of May 2021.

    Stated by Medicines and Healthcare products Regulatory AgencyStated plannedThe respondent said that this action was planned when they made their response on 8 January 2021.
  6. 6

    Consider existing medical-estate data on food-related anaphylaxis and how to analyse and use it to prevent future incidents and deaths.

    Stated by Department of Health and Social CareStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  7. 7

    Support businesses, consumers and local authorities to prepare for new prepacked-for-direct-sale allergen labelling rules.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  8. 8

    Launch a communications campaign encouraging 18–21-year-olds to disclose allergies when ordering from food businesses.

    Stated by Food Standards AgencyStated plannedThe respondent said that this action was planned when they made their response on 8 January 2021.
  9. 9

    Refresh online allergy and intolerance training for businesses and local authorities.

    Stated by Food Standards AgencyStated completedThe respondent said that this action was complete when they made their response on 8 January 2021.
  10. 10

    Plan and hold a second Allergy Symposium for industry, enforcement bodies, consumer groups and clinicians.

    Stated by Food Standards AgencyStated plannedThe respondent said that this action was planned when they made their response on 8 January 2021.
  11. 11

    Monitor trends in severe non-fatal food-induced allergic reactions and identify people at greatest risk of severe anaphylaxis.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  12. 12

    Launch a registry collecting detailed clinical information about anaphylactic reactions.

    Stated by Food Standards AgencyStated plannedThe respondent said that this action was planned when they made their response on 8 January 2021.
  13. 13

    Collect additional reports and user insights on non-fatal food-allergic reactions to identify emerging patterns.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  14. 14

    Interview people who experienced near-fatal food anaphylaxis about the circumstances and context of their events.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  15. 15

    Consider the benefits of developing a food allergy safety scheme for allergen management in food businesses.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.
  16. 16

    Discuss with DHSC how to analyse and evaluate data sources on fatal allergic reactions.

    Stated by Food Standards AgencyStated in progressThe respondent said that this action was in progress when they made their response on 8 January 2021.

Recipient positions A position is what a recipient says about a concern when they do not describe a specific action.2

  1. 1

    Responsibility for regulating and responding to concerns about AAI availability rests with the MHRA.

    Stated by Department of Health and Social CareRedirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.
  2. 2

    Action on availability of emergency adrenaline auto-injectors in retail food settings is best addressed by other named bodies.

    Stated by Food Standards AgencyRedirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Advance progress towards an effective, safe and legally implemented mechanism for widening access to adrenaline auto-injectors.

Verbatim wording from the response

“The MHRA hopes that this initiative will provide you and the Court with reassurance that the matter has been, and is continuing to be, officially investigated and that the MHRA views this as a matter of significant public health importance. The MHRA will continue to advance progress towards an effective and safe, legally implemented, mechanism of widening access to AAIs in order to save lives in the future. This will also need to ensure that the future supply of AAIs will be able to meet the additional demand for AAIs that wider roll-out would bring, without compromising the supply of prescribed AAIs that remain the mainstay for protecting individuals at risk.”

Source location

2020-0298-Response-from-MHRA-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Seek expert advice on areas supporting the effective and safe use of adrenaline auto-injectors, including wider availability.

Verbatim wording from the response

“The Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health and Social Care (DHSC), is responsible for the regulation of medicines in the UK. In 2019 and 2020 MHRA sought advice from the UK Commission on Human Medicines (CHM), its independent scientific advisory committee, on a range of areas to support the effective and safe use of AAIs. Members of the CHM include a range of clinical and technical experts and lay representatives. CHM advice was sought after coroners’ inquests into fatalities from anaphylaxis highlighted a range of issues in relation to the prescribing and use of AAIs. The feasibility of making AAIs available in the wider community, as a means of providing emergency treatment for anaphylaxis in exceptional circumstances, was also raised.”

Source location

2020-0298-Response-from-MHRA-Redacted
Page 1 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Endorse the Expert Working Group’s conclusions and recommendations on adrenaline auto-injector safety and wider availability.

Verbatim wording from the response

“effective and safe use of AAIs for the emergency treatment of anaphylaxis, including wider availability. The AAI EWG met on a number of occasions between April and July 2020 during which a number of areas were examined and a series of recommendations were made. In July 2020 CHM endorsed the conclusions and recommendations of the AAI EWG and made some additional recommendations.”

Source location

2020-0298-Response-from-MHRA-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Establish and convene an Adrenaline Auto-injector Expert Working Group to examine safe use, wider availability and related safeguards.

Verbatim wording from the response

“In March 2020 the CHM agreed to the formation, and Terms of Reference, of an Adrenaline Auto-injector Expert Working Group (AAI EWG) to examine a range of cross-cutting areas to support the”

Source location

2020-0298-Response-from-MHRA-Redacted
Page 1 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Publish a report summarising the Expert Working Group’s conclusions and recommendations by the end of May 2021.

Verbatim wording from the response

“A report summarising the conclusions and recommendations of the AAI EWG, endorsed by the CHM, will be published by the end of May 2021.”

Source location

2020-0298-Response-from-MHRA-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Consider existing medical-estate data on food-related anaphylaxis and how to analyse and use it to prevent future incidents and deaths.

Verbatim wording from the response

“Furthermore, officials from the Department and the FSA are together considering the existing data available from across the medical estate on food-related anaphylaxis cases, and how this might be analysed and used to prevent future incidents and deaths. The intention is to understand what more both Departments are able to do in this area.”

Source location

2020-0298-Response-from-Dept-for-Health-and-Social-Care-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Support businesses, consumers and local authorities to prepare for new prepacked-for-direct-sale allergen labelling rules.

Verbatim wording from the response

“• We are supporting businesses, consumers and local authorities to prepare for new allergen labelling rules for ‘prepacked for direct sale’ food that come into effect on the 1st October 2021. This legislation will require that these types of products have full ingredients labelling with the allergens emphasised. This is a step forward in the provision of allergen information for allergic consumers and will help enable consumers to make safe and informed choices when eating out.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 3 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Launch a communications campaign encouraging 18–21-year-olds to disclose allergies when ordering from food businesses.

Verbatim wording from the response

“• Raising awareness amongst hypersensitive consumers is a key part of our work. The FSA will soon be launching a new communications campaign targeting 18-21 year olds to encourage them to speak up about their allergies when ordering from food businesses.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 3 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Refresh online allergy and intolerance training for businesses and local authorities.

Verbatim wording from the response

“• In September 2020 we refreshed our online allergy and intolerance training aimed at businesses and local authorities to improve the content and overall clarity. To date, we have had a significant number of users sign up to the training, including 48% (17,639) from food businesses who can learn more about how to handle allergens safely in a food business environment.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 3 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Plan and hold a second Allergy Symposium for industry, enforcement bodies, consumer groups and clinicians.

Verbatim wording from the response

“• We are planning a second Allergy Symposium this year to bring together industry, enforcement bodies, consumer groups and clinicians to explore the complexities of managing allergens, showcase good practice, while expanding awareness of food hypersensitivity and assisting food businesses to achieve compliance.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 3 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Monitor trends in severe non-fatal food-induced allergic reactions and identify people at greatest risk of severe anaphylaxis.

Verbatim wording from the response

“• The FSA has also commissioned work that uses data to monitor trends in the occurrence of severe, food-induced allergic reactions which do not result in death and to help identify those most at risk of severe anaphylaxis. This includes the establishment of a registry to collect detailed, clinical information around the circumstances of anaphylactic reactions. This will be launched in the coming months. The project also identifies individuals who have experienced near-fatal food anaphylaxis and undertakes detailed interviews to provide information regarding the circumstances and context of the anaphylaxis event. This work will report towards the end of next year.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Launch a registry collecting detailed clinical information about anaphylactic reactions.

Verbatim wording from the response

“• The FSA has also commissioned work that uses data to monitor trends in the occurrence of severe, food-induced allergic reactions which do not result in death and to help identify those most at risk of severe anaphylaxis. This includes the establishment of a registry to collect detailed, clinical information around the circumstances of anaphylactic reactions. This will be launched in the coming months. The project also identifies individuals who have experienced near-fatal food anaphylaxis and undertakes detailed interviews to provide information regarding the circumstances and context of the anaphylaxis event. This work will report towards the end of next year.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Collect additional reports and user insights on non-fatal food-allergic reactions to identify emerging patterns.

Verbatim wording from the response

“• The FSA has started work on a project designed to collect more reported data on food-based allergic reactions that do not result in death. Work on this project is progressing despite some disruption due to the COVID-19 pandemic. We are currently undertaking discovery work with people with allergies to understand the type of information that they could provide and the data that the FSA could receive on allergic reactions. This will enable us to assess expectations and the perceived usefulness of such a reporting mechanism. The result of this work would not equate to a national reporting system, but it would provide us with valuable information on emerging patterns and help us to build a better picture of the reactions experienced by allergic consumers.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Interview people who experienced near-fatal food anaphylaxis about the circumstances and context of their events.

Verbatim wording from the response

“• The FSA has also commissioned work that uses data to monitor trends in the occurrence of severe, food-induced allergic reactions which do not result in death and to help identify those most at risk of severe anaphylaxis. This includes the establishment of a registry to collect detailed, clinical information around the circumstances of anaphylactic reactions. This will be launched in the coming months. The project also identifies individuals who have experienced near-fatal food anaphylaxis and undertakes detailed interviews to provide information regarding the circumstances and context of the anaphylaxis event. This work will report towards the end of next year.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Consider the benefits of developing a food allergy safety scheme for allergen management in food businesses.

Verbatim wording from the response

“• We are considering the benefits of developing a food allergy safety scheme for allergen management within food businesses, through gathering a range of information, including the views of hypersensitive consumers. Such a scheme would help consumers in a similar way to the Food Hygiene Rating Scheme, enabling them to trust food businesses and to make choices safely.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 3 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Discuss with DHSC how to analyse and evaluate data sources on fatal allergic reactions.

Verbatim wording from the response

“• Separately, whilst it is not within FSA’s remit to establish a national register of fatalities, given their medical and clinical responsibilities in this area, we are discussing with the Department for Health and Social Care (DHSC) how we could analyse and evaluate different data sources to give us a clearer picture of allergic reactions that result in fatality.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Responsibility for regulating and responding to concerns about AAI availability rests with the MHRA.

Verbatim wording from the response

“In relation to your second matter of concern regarding the availability of emergency Adrenaline Auto-injector (AAI) devices in the retail food sector, my officials have liaised with the Medicines and Healthcare products Regulatory Agency (the MHRA), which is responsible for the regulation of medicines in the UK.”

Source location

2020-0298-Response-from-Dept-for-Health-and-Social-Care-Redacted
Page 2 · response
Published 8 January 2021

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Action on availability of emergency adrenaline auto-injectors in retail food settings is best addressed by other named bodies.

Verbatim wording from the response

“The FSA respectfully considers that action in this area is a matter best addressed by the other key recipients, namely the DHSC, the Royal College of Paediatrics and Child Health, ROSPA and Health and Safety Executive.”

Source location

2020-0298-Response-from-Food-Standards-Agency-Redacted
Page 2 · response
Published 8 January 2021

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
3/3

Data last updated 7 September 2026